Lukas Goerdt, Carl Zeiss Meditec (F), Heidelberg Engineering (F), Optos (F);
Maximilian Pfau, Alimera Sciences (R), Carl Zeiss Meditec (F), Carl Zeiss Meditec (I), Genentech (F), Heidelberg Engineering (F), Heidelberg Engineering (R), Optos (F);
Moritz Lindner, Alimera Sciences (R), Carl Zeiss Meditec (F), Carl Zeiss Meditec (I), Genentech (F), Heidelberg Engineering (F), Heidelberg Engineering (R), Optos (F);
Sarah Thiele, Alimera Sciences (R), Carl Zeiss Meditec (F), Carl Zeiss Meditec (I), Genentech (F), Heidelberg Engineering (F), Heidelberg Engineering (R), Optos (F);
Jennifer Nadal, None;
Matthias Schmid, None;
Steffen Schmitz-Valckenberg, Alcon/Novartis (F), Alcon/Novartis (C), Allergan (F), Bayer HealthCare (F), Bayer HealthCare (R), Carl Zeiss Meditec (F), Formycon (F), Genentech/Roche (F), Heidelberg Engineering (R), Heidelberg Engineering (F), Optos (F);
Frank Holz, Acucela (F), Acucela (C), Allergan (F), Allergan (R), Bayer (F), Bayer (C), Bayer (R), Bioeq (F), Bioeq (C), Boehringer-Ingelheim (C), Genentech/Roche (F), Genentech/Roche (C), Genentech/Roche (R), Heidelberg Engineering (F), Heidelberg Engineering (C), Heidelberg Engineering (R), Merz (C), NightstarX (F), Novartis (C), Novartis (R), Optos (F), Pixium (F), Thea (C), Zeiss (F), Zeiss (R);
Monika Fleckenstein, Bayer HealthCare (R), Carl Zeiss Meditec (F), Genentech (F), Genentech (R), Heidelberg Engineering (R), Heidelberg Engineering (F), Merz (C), Novartis (R), Optos (F), US20140303013 (P)